This finding is consistent with previous reports on cervical cancer (24), which found that the expression of NR2F6 was significantly correlated with the clinical stage, survival status, tumor recurrence, chemotherapy, and lymph node metastasis of cervical cancer. This evidence concerns the gene NR2F6 and metastatic malignant neoplasm in the lymph nodes.